Sant Pau Hospital
Barcelona, Spain
NCT Number: NCT06261944
The main clinical study objective is to confirm the accuracy of the Glyconics-DS spectrometer when used in its intended medical purpose population, i.e., in individuals with unknown diabetes risk. Additionally, this investigation will serve as a pivotal performance evaluation for the associated software for correct delivery of the algorithm-based analysis of the individual diabetes risk. The study will be considered positive if the backend delivery of the chemometrics output is performed correctly as per the cloud-based analysis and its delivery represents the essential medical software to be evaluated in this investigation. The 'true' diabetes risk will be contrasted against values of an internal biomarker indicative of glycaemia, HbA1c, as measured based on standardised, certified methodology.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Barcelona, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Near-infrared assessment of glycated keratin in middle fingernail
Time frame: 10 seconds
YELLOW: HbA1c value < 48 mmol/mol OR ORANGE: HbA1c value >= 48 mmol/mol.
Time frame: 10 seconds
HbA1c cut-off value of 48 mmol/mol (6.5%) and HbA1c cut-off value of 42 mmol/mol (6.0%)
Glyconics Ltd
Industry
A Pivotal Multi-centre, Open-label, Two-part Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package Delivering the Dichotomised Results
Acronym: ANODE03
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06173765
Glucose Intolerance, Glucose Metabolism Disorders
Chicago, Illinois, United States
View Trial DetailsNCT05965973
Glucose Intolerance, Glucose Metabolism Disorders
Québec, Quebec, Canada
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT03077360
Body Weight, Diabetes Mellitus
Aurora, Colorado, United States
View Trial Details